NUCLEOLIN and cancer: Here, the interaction of these ligandswith the AT11 aptamer, ableto specifically recognize nucleolin overexpressed on the surface ofcancer cells,−,  was evaluated to exploit their binding to G-quadruplex-formingaptamers so as to obtain efficient drug/carrier systems for the selectivedelivery of G-quadruplex-targeting natural ligands into cancer cells.